Troponwerke Gmbh & Co Kg

Bayer Aktiengesellschaft

Troponwerke Gmbh & Co.

Hans-Dieter Dell

Reinhold Kraus

Haireddin Jacobi

Detlef Schierstedt

Karl-Heinz Boltze

Wolfgang Opitz

Bernhard Pelster

Harald Horstmann

Peter-Rudolf Seidel

Eugen Etschenberg

Gunter Schollnhammer

Eugen Etscherberg

Helmut H Schwarz

Bernhard Beckermann

The invention relates to pellet formulations which (a) contain at least one active compound, one binder and one weighting agent, (b) are coated with a lacquer which is resistant to gastric juice or have been granulated in the presence of a lacquer which is resistant to gastric juice, it being possible, if appropriate, for the granules to be coated with a lacquer which is resistant to gastric juice, (c) have an apparent density of 1.4 to 2.4 and (d) have a diameter of 0.2 to 1.8 mm.

Pellet formulation

Medicament preparations contain 2-(2-hydroxyethoxy)-ethyl N-(.alpha.,.alpha.,.alpha.-trifluoro-m-tolyl)-anthranilate and dimethyl sulphoxide.

Medicament preparations

The invention relates to topical antiinflammatory medicament formulations which also have analgesic activity and contain 2-(2-hydroxyethoxy)-ethyl N-(.alpha.,.alpha.,.alpha.,-trifluoro-m-tolyl) anthranilate as the active ingredient and an adjuvant which is preferably a triglyceride.

Etofenamate formulation

The invention relates to depot formulations containing, as an active antiinflammatory and/or analgesic agent a compound of Formula I, infra together with a suspension medium. Typical suspension agents are glycerides and/or esters of mono- or poly-hydric alcohols as well as selected ethers, alcohols and amides.

Depot antiinflammatory agents

The present invention relates to certain new 7,8,9,10-tetrahydrothieno[3,2-e]pyrido[4,3-b]indole compound, to a process for their production and to their use as agents which have an influence on the central nervous system. The ring system according to the invention has not hitherto been described in the literature.

7,8,9,10-Tetrahydrothieno[3,2-e]pyrido[4,3-b]indole compounds and their

The invention relates to 2-oxo-1-pyrrolidineacetic acid compounds, useful as psychopharmacological agents. Also included in the invention are pharmaceutical compositions containing said compounds and methods for the use of said compounds and compositions.

2-Oxo-1-pyrrolidineacetic acid compounds and their medicinal use

The present invention provides, inter alia, antiphlogistically effective agents, including pharmaceutical compositions containing said agents. Also included are methods for the use of said agents. The active compounds are those of the formula ##STR1## or an ester thereof, in which X denotes a hydrogen atom, an alkyl group, an alkoxy group, an alkylthio group, an alkylsulphinyl or alkylsulphonyl group or a hydroxyl or mercapto group,

Growing community of inventors

Bergisch-Gladbach, Germany

Hans-Dieter Dell